Clinical trials in malignant pleural mesothelioma in Australasia

Anna Nowak

doi:10.1016/j.lungcan.2005.03.021

Clinical trials in malignant pleural mesothelioma in Australasia

Anna Nowak

Graduate Research School

Research output: Contribution to journal › Article › peer-review

Abstract

Australasia has a strong record in clinical trials in malignant pleural. mesothelioma (MPM), driven by the relatively high incidence of this disease in the region. Two current and three proposed trials in mesothelioma in this region are discussed, covering the diverse clinical scenarios of diagnosis and staging, health-related quality of life, maintenance therapy, prediction of response and combined modality treatment. (c) 2005 Elsevier Ireland Ltd. All rights reserved.

Original language	English
Pages (from-to)	S113-S116
Journal	Lung Cancer
Volume	49
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1016/j.lungcan.2005.03.021
Publication status	Published - 2005

Access to Document

10.1016/j.lungcan.2005.03.021

Cite this

@article{bbd451cbcd3e49628e2a5058bac6a420,

title = "Clinical trials in malignant pleural mesothelioma in Australasia",

abstract = "Australasia has a strong record in clinical trials in malignant pleural. mesothelioma (MPM), driven by the relatively high incidence of this disease in the region. Two current and three proposed trials in mesothelioma in this region are discussed, covering the diverse clinical scenarios of diagnosis and staging, health-related quality of life, maintenance therapy, prediction of response and combined modality treatment. (c) 2005 Elsevier Ireland Ltd. All rights reserved.",

author = "Anna Nowak",

year = "2005",

doi = "10.1016/j.lungcan.2005.03.021",

language = "English",

volume = "49",

pages = "S113--S116",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier",

number = "SUPPL. 1",

}

TY - JOUR

T1 - Clinical trials in malignant pleural mesothelioma in Australasia

AU - Nowak, Anna

PY - 2005

Y1 - 2005

N2 - Australasia has a strong record in clinical trials in malignant pleural. mesothelioma (MPM), driven by the relatively high incidence of this disease in the region. Two current and three proposed trials in mesothelioma in this region are discussed, covering the diverse clinical scenarios of diagnosis and staging, health-related quality of life, maintenance therapy, prediction of response and combined modality treatment. (c) 2005 Elsevier Ireland Ltd. All rights reserved.

AB - Australasia has a strong record in clinical trials in malignant pleural. mesothelioma (MPM), driven by the relatively high incidence of this disease in the region. Two current and three proposed trials in mesothelioma in this region are discussed, covering the diverse clinical scenarios of diagnosis and staging, health-related quality of life, maintenance therapy, prediction of response and combined modality treatment. (c) 2005 Elsevier Ireland Ltd. All rights reserved.

U2 - 10.1016/j.lungcan.2005.03.021

DO - 10.1016/j.lungcan.2005.03.021

M3 - Article

C2 - 15950790

VL - 49

SP - S113-S116

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - SUPPL. 1

ER -

Clinical trials in malignant pleural mesothelioma in Australasia

Abstract

Access to Document

Fingerprint

Cite this